Literature DB >> 17276269

Reducing the risk for endophthalmitis after cataract surgery: population-based nested case-control study: endophthalmitis population study of Western Australia sixth report.

Jonathon Q Ng1, Nigel Morlet, Max K Bulsara, James B Semmens.   

Abstract

PURPOSE: To characterize operative and nonoperative risks for the potentially blinding complication of endophthalmitis after cataract surgery.
SETTING: Ophthalmology services for the whole state of Western Australia.
METHODS: This retrospective population-based nested case-control study in Western Australia covered the period between 1980 and 2000. For each of the 205 cases of endophthalmitis, 4 time-matched controls were randomly selected from all cataract operations performed in the state. Conditional logistic regression was used to estimate multivariate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the risk factors of interest.
RESULTS: Wound location, suturing the wound, and type of cataract operation did not affect the risk for postoperative endophthalmitis. Antibiotic prophylaxis reduced the risk, but only if given as a subconjunctival injection (OR, 0.46; 95% CI, 0.29-0.70). The risk for endophthalmitis was greater with same-day surgery (OR, 2.27; 95% CI, 1.52-3.41) than with admission the day before surgery. A concurrent eyelid procedure was a substantial risk. Surgeons within 2 years of obtaining specialist qualifications were more likely to have a case of endophthalmitis, although this was partly the result of more posterior capsule breaches. Posterior capsule breach increased the risk when it occurred in private hospitals (OR, 13.57; 95% CI, 4.00-45.99), but not in public hospitals.
CONCLUSIONS: Nonoperative as well as operative factors are important in the prevention of endophthalmitis. Subconjunctival injection of antibiotics appears to be beneficial for endophthalmitis prophylaxis. The model showed that active risk management strategies designed to optimize hospitalization and chemoprophylaxis may reduce the incidence of endophthalmitis by up to 81%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276269     DOI: 10.1016/j.jcrs.2006.10.067

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  Postcataract surgery endophthalmitis in the United States: analysis of the complete 2003 to 2004 Medicare database of cataract surgeries.

Authors:  Lisa Keay; Emily W Gower; Sandra D Cassard; James M Tielsch; Oliver D Schein
Journal:  Ophthalmology       Date:  2012-01-31       Impact factor: 12.079

2.  Risk factors for endophthalmitis following cataract surgery-our experience at a tertiary eye care centre in India.

Authors:  Rohit C Khanna; Vanita Pathak Ray; Madhavi Latha; Sandra D Cassard; Annie Mathai; Garudadri C Sekhar
Journal:  Int J Ophthalmol       Date:  2015-12-18       Impact factor: 1.779

3.  Impact of intracameral cefuroxime on the incidence of postoperative endophthalmitis following cataract surgery in Ireland.

Authors:  N Rahman; C C Murphy
Journal:  Ir J Med Sci       Date:  2014-05-21       Impact factor: 1.568

Review 4.  Prophylaxis of postoperative endophthalmitis following cataract surgery: current status and future directions.

Authors:  Robert E Fintelmann; Ayman Naseri
Journal:  Drugs       Date:  2010-07-30       Impact factor: 9.546

5.  Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.

Authors:  Randy C Bowen; Andrew Xingyu Zhou; Sailaja Bondalapati; Thomas W Lawyer; Karisa B Snow; Patrick R Evans; Tyler Bardsley; Mary McFarland; Matthew Kliethermes; Dallas Shi; Christina A Mamalis; Tom Greene; Christopher J Rudnisky; Balamurali Krishna Ambati
Journal:  Br J Ophthalmol       Date:  2018-01-11       Impact factor: 4.638

6.  Management strategies to reduce risk of postoperative infections.

Authors:  Anat Galor; Raquel Goldhardt; Sarah R Wellik; Ninel Z Gregori; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2013-12

7.  MRSA and cataract surgery - reflections for practice.

Authors:  L F Porter; R U Khan; A Hannan; S P Kelly
Journal:  Clin Ophthalmol       Date:  2010-10-21

8.  Efficacy and tolerability of a combined moxifloxacin/dexamethasone formulation for topical prophylaxis in phacoemulsification: an open-label single-arm clinical trial.

Authors:  Cesar Ramon G Espiritu; Mary Ellen A Sy; Tommee Lynne G Tayengco
Journal:  J Ophthalmol       Date:  2011-05-25       Impact factor: 1.909

9.  A case-control study of post-operative endophthalmitis diagnosed at a Spanish hospital over a 13-year-period.

Authors:  M A Asencio; M Huertas; R Carranza; J M Tenias; J Celis; F Gonzalez-Del Valle
Journal:  Epidemiol Infect       Date:  2014-03-11       Impact factor: 4.434

10.  Efficacy of intraoperative vancomycin in irrigating solutions on aqueous contamination during phacoemulsification.

Authors:  Renuka Srinivasan; Arvind Gupta; Subashini Kaliaperumal; Ramesh K Babu; Senthil Kumar Thimmarayan; Harish Narasimha Belgode
Journal:  Indian J Ophthalmol       Date:  2008 Sep-Oct       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.